Zonare develops and markets premium and high-end image quality compact ultrasound systems within a wide range of clinical settings.
The company is able to offer better and faster images at a lower price point than conventional systems thus improving efficiency and diagnosis. Zonare strives to drive medical advances and innovation to continue to launch high performing products for the benefits of the practitioners and the patients.
The company achieved steady growth over the course of Apposite’s investment and became profitable by the time of exit. In 2012, it successfully launched its next generation high frequency ultrasound product which allows deeper tissue penetration and tailoring of the image parameters to the patient.
The company was acquired by Mindray Medical in July 2013.